Validating its oncogenic functions in mouse models, Ctbp2 haploinsufficiency dramatically reduced intestinal polyposis and prolonged survival in the Apcmin intestinal polyposis model and also extended survival and attenuated peritoneal metastasis in a mutant K-Ras–driven mouse PDAC model (13). Here, KRAS is linked to gastrointestinal polyp.